Translational research for cancer vaccine therapy with poxviral vectors expressing TAA and costimulatory molecules

Medicine & Life Sciences

• Active Immunotherapy 100%
• Allergy and Immunology 11%
• Cancer Vaccines 92%
• Clinical Trials 7%
• Drug Therapy 6%
• Immunotherapy 9%
• Japan 9%
• Neoplasm Antigens 81%
• Neoplasms 24%
• Radiotherapy 7%
• T-Lymphocytes 6%
• Therapeutics 5%
• Transgenes 11%
• Translational Medical Research 86%
• Vaccines 16%